Cargando…
mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation
Breast cancer is the leading cause of cancer-related deaths among women. Approximately 75% of breast cancers are estrogen receptor α (ERα) positive, underscoring the dependence of cancer cells on estrogen for growth and survival. Patients treated with endocrine therapy often develop resistance, eith...
Autores principales: | Alayev, A, Salamon, R S, Berger, S M, Schwartz, N S, Cuesta, R, Snyder, R B, Holz, M K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853282/ https://www.ncbi.nlm.nih.gov/pubmed/26522726 http://dx.doi.org/10.1038/onc.2015.414 |
Ejemplares similares
-
Phosphoproteomics Reveals
Resveratrol-Dependent Inhibition
of Akt/mTORC1/S6K1 Signaling
por: Alayev, Anya, et al.
Publicado: (2014) -
Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2
por: Luo, Yan, et al.
Publicado: (2015) -
mTORC1 phosphorylates LARP6 to stimulate type I collagen expression
por: Zhang, Yujie, et al.
Publicado: (2017) -
Estrogen receptor alpha drives mTORC1 inhibitor-induced feedback activation of PI3K/AKT in ER+ breast cancer
por: Yang, Wei, et al.
Publicado: (2018) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016)